-
Should Gilead Buy Vertex?
Tuesday, April 21, 2015 - 11:44am | 351Adam Feuerstein of TheStreet.com on Tuesday discussed the merits of Gilead Sciences, Inc. (NASDAQ: GILD) acquiring Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Tuesday. Feuerstein highlighted a report from Bernstein analyst Geoff Porges that suggested Gilead’s “long...